Notice Regarding the Completion of Purchase of the Company's Own Shares in the Market
(Buyback of shares pursuant to the provision of its Articles of Incorporation in accordance with Article 165, paragraph 2 of the Companies Act)
|
|
Osaka, Japan, March 26, 2008---Santen Pharmaceutical Co., Ltd. announced that the Company has aquired its own shares in the market pursunt to the provisions of Article 156 which is applicable in accordance to Article 165, paragraph 3 of the Companies Act of Japan, as follows. The stock acquisition, decided at the Board of Directors meeting held on January 30, 2008, has been completed through this buyback.
| 1. Period of purchase: |
|
From March 3, 2008 to March 24, 2008 |
| 2. Total number of shares purchased: |
|
826,100 shares |
| 3. Total amount paid for shares: |
|
2,025,018,000 yen |
| 4. Method of purchase: |
|
Purchased through the Osaka Stock Exchange |
Reference:
1. Contents of the resolution at the Board of Directors Meeting held on January 30, 2008
| (1) Type of shares to be purchased: |
|
Common stock of the company |
| (2) Total number of shares to be purchased: |
|
1,850,000 shares (maximum) |
| (3) Gross amount of shares to be purchased: |
|
5,000,000,000 yen (maximum) |
| (4) Period of purchase: |
|
From February 1, 2008 to March 24, 2008 |
2. Total number of shares and costs on or after the Board of Directors Meeting held on January 30, 2008.
| (1) Total number of shares purchased: |
|
1,833,800 shares |
| (2) Total amount paid for shares: |
|
4,800,509,500 yen |
|
|
|
|
Back to top
|
|
|
|
